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Abstract The gene for human uracil-DNA glycosylase (UNG) contains 4 exons and has an approximate size of 13 kb. The promoter is very GC 
rich and lacks a TATA box. Nested deletions of the promoter demonstrated that two SP1 elements and a putative c-MYC element proximal to the 
transcription i itiation region were sufficient o support some 27% of the promoter activity, while a clone that in addition contained the elements 
E2F/SPI/CCAAT increased expression to almost 90% of the full-length construct. A region upstream of these elements appears to exert a negative 
control function. 
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1. Introduction 
Uraci l -DNA glycosylase (UNG) initiates the base excision 
repair pathway for removal of uracil from DNA. The succes- 
sive steps in the base excision repair pathway are thought o 
involve action of an AP endonuclease, DNA deoxyri- 
bophosphodiesterase, a DNA polymerase and a DNA ligase 
[1,2]. Uracil in DNA results from deamination of cytosine [3] 
or incorporation ofdUMP instead of dTMP [4,5]. Deamination 
will result in a GC to AT transition mutation unless uracil is 
removed before the next round of replication. It has been hy- 
pothesized that incorporated dUMP, or strand breaks resulting 
from repair of newly replicated DNA, may have a role in strand 
selection in mismatch repair (reviewed in [6]), but to our knowl- 
edge there is no direct experimental evidence supporting this 
view. E. coli mutants in the ung-gene ncoding uraci l -DNA 
glycosylase show some 5-fold increased spontaneous mutation 
rate [7] rising to 30-fold at certain bases [8], whereas a 20-fold 
increase in spontaneous mutations has been found in similar 
yeast mutants [9]. Mammalian mutants in the UNG-gene are 
not available. UNG has been purified from human placenta [10] 
and the corresponding cDNA cloned [11]. This cDNA encodes 
the major nuclear form, as well as the mitochondrial form of 
the enzyme [12,13]. The UNG-protein shows a striking similar- 
ity to analogous enzymes from E. coli [14], Streptococcuspneu- 
moniae [15], animal viruses [16-19] and Saccharomyces cere- 
visiae [20]. Although all human cells and tissues investigated 
have measurable UNG activities, significant interindividual s 
well as interorgan variation in activities has been observed in 
extracts from human adult tissues [21,22]. Furthermore, stimu- 
lation of peripheral lymphocytes with phytohemagglutinin, a d 
studies of cells with different proliferation rates have demon- 
strated a correlation between UNG activity and DNA synthesis 
[23-25]. Transcription of the UNG gene is induced late in the 
Gl-phase resulting in an 8-12 fold increase in the transcript 
level, and the pattern of UNG accumulation i dicated that the 
gene expression is regulated mainly at the transcriptional level 
[12]. These results together with the experiments demonstrating 
an association between UNG and replicating SV40 minichro- 
mosomes [26], indicate a coordinated expression of UNG and 
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proteins involved in DNA synthesis. However, specific inhibi- 
tion of DNA replication by aphidicolin indicated that although 
the accumulation of UNG is temporally correlated with induc- 
tion of the S-phase, it is not dependent on active DNA synthesis 
[12]. 
In the present work, we present he structure of the UNG 
gene and the organization of a TATA-less and very GC-rich 
upstream sequence containing a highly active promoter with 
recognition sites for several transcription factors. 
2. Materials and methods 
2.1. Southern analysis of the UNG gene structure 
High molecular weight DNA was prepared from human leukocytes 
by phenol/chloroform extraction and isopropyl alcohol precipitation 
using a model 340A Nucleic Acid Extractor (Applied Biosystems). 
10/.tg DNA were digested with 30~0 U of restriction enzyme and 
separated on 0.8% agarose gels. The DNA was transferred to 
GeneScreenPlus membranes and hybridized with 32p-labelled cDNA 
probes as described [28], except hat 65°C and 1% SDS were used. 
According to the numbering of the cDNA [11], the following probes 
were used: 1-301, 301-546, 546-1140, 1140-2074, 1468-2074. The 
membranes were subjected to a final wash in 0.1 x SSC/0.5% (w/v) SDS, 
65°C for 1 h and autoradiographed on Kodak X-Omat film for 6-10 
days with intensifying screens. 
2.2. Inverse PCR 
High molecular weight DNA (20/tg) was digested with 32 U RmaI 
overnight and separated on a 0.8% low melting point agarose gel. The 
region of the gel corresponding to 1.3 kb was cut out and DNA isolated 
from the gel using Gelase (Epicentre Technologies). The DNA was 
dissolved in 20/tl dH20. 200 ng of the isolated RmaI fragments were 
circularized in a 50/tl igation mixture overnight at 16°C. After addition 
of carrier tRNA to a final concentration f 50 ng per/A, the DNA was 
finally precipitated with NH4Ac and ethanol. The PCR reaction was 
carried out on a Perkin Elmer thermo cycler in 100/.tl with the supplied 
1 x Vent buffer, 200/tM of each dNTP, 30 pmol of primer 1+ (5'- 
CCAAGGCAGAAGACGCCCATTTGT-3') and primer 1- (5'-CG- 
CCTCTGCGGGGACCACTTGC-3') using the circularized RmaI 
fragments resuspended in dH20 as template. The template was dena- 
tured for 5 min at 95°C and the temperature lowered to 90°C before 
addition of 2 U Vent polymerase (New England Biolabs) and two 
droplets of light mineral oil. Conditions for the 35 cycles were 1 min 
at 950C, 1.5 min at 65°C and 2 min at 74°C. To ensure the specificity 
of the product, a nested PCR reaction was carried out under the same 
conditions using about 1 ng of the first PCR product as template 
together with primer 2+ (5'-CCCAGCAAAAGCGGACAGTAAGA- 
GC-3") and primer 2-  (5'-CGCTGAGTGCCGAGCAGTTGGA-3'). 
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This PCR product was cloned into the plasmid pCR 1000 (Invitrogen), 
transformed into an E. coli strain (Epicurian Coli SURE from 
Stratagene) and sequenced by Sanger's ddNTP method using 7-deaza- 
guanosine triphosphate and primer walking with 14 primers. The se- 
quence was determined on both strands. 
2.3. Preparation of a promoter-reporter gene construct and transient 
transfections 
By adding an XhoI and a HindlII linker, the sequence from 42 to 440 
was cloned in the correct orientation i to the polylinker of pGL2-Basic 
(Promega) and named pGL2-ProB. The pGL2-Basic vector carries the 
coding region for firefly (Photinus pyralis) luciferase which was used to 
monitor transcriptional activity in transfected cells. Using the Erase-A- 
Base system (Promega), several deletion clones were generated and 
transiently transfected into HeLa cells using Transfectam (Promega). 
5 gg DNA were mixed with 25 gg Transfectam in I ml medium without 
serum and added to 106 adherent HeLa cells. After 7 h the DNA- 
Transfectam ixture was removed and medium with serum added. 
After 14 h the cells were lyzed in 250gl of 25 mM Tris-phosphate, pH 
7.8, 2 mM dithiothreitol, 2 mM 1,2-diaminocyclohexane-N,N,N',N'- 
tetraacetic acid, 10% glycerol and 1% Triton X-100. Cell debris was 
removed from the supernatant by centrifugation. 20 gl of the superna- 
tant were added to 100 gl Luciferase Assay substrate (Promega). Pho- 
tons were counted by scintillation counting (Packard, Model 1900CA) 
using a 3H-window and single photon counting mode. The samples were 
counted in 10 consecutive periodes of 20 s immediately after addition 
of the substrate. The activity detected in the fourth period was used for 
comparison with the other samples. 
2.4. Analysis of protein binding 
Binding of transcription factors to the promoter region was investi- 
gated using gel mobility shift assays. SP1 analysis was performed by 
incubating 200 pg of a 150 bp radioactively labelled BglIIAvaI fragment 
(position 218 to 368), containing the putative SP1 binding sites, with 
4 ng of purified Spl (Promega). The incubation took place in a buffer 
consisting of 10 mM Tris-HCi (pH 7.5), 50 mM NaCI, 0.5 mM DTT, 
10% glycerol, 0.05% NP-40 and 3 pg poly(dI-dC), poly(dI-dC) at room 
temperature for 20-30 min in a total volume of 20 pl. The AP2 assay 
was similarly performed with a 149 bp EcoNIINarI fragment (position 
42 to 191) incubated with 560 ng purified Ap2 in 25 mM Tris-HCl (pH 
8), 6.25 mM MgCI, 0.5 mM EDTA, 10% glycerol, 0.5 mM D'vr and 
1 pmol AP1 oligonucleotide (Promega) as unspecific ompetitor. The 
reactions were separated on a 5% non-denaturing polyacrylamide g l. 
For analysis of E2F binding, 0.05 pmol of a radioactively labelled 
24-mer oligonucleotide (corresponding to position 270 to 294) contain- 
ing the putative binding site for E2F was incubated in a total volume 
of 20/tl with HeLa nuclear extract containing approximately 25 ng 
protein in 10 mM Tris-HCl (pH 7.5), 50 mM NaC1, 0.5 mM DTT, 10% 
glycerol, 0.05% NP-40 and 2 pmol Octl oligonucleotide (Promega) as 
unspecific ompetitor. For supershift assays 2 gg E2F-1 Tranz Cruz Gel 
Supershift Antibody (Santa Cruz Biotechnology) were added to the 
binding reaction after 30 min for additional 60 min incubation. Separa- 
tion of various products was carried out on a 7% non-denaturing 
polyacrylamide g l. 
3.  Resu l t s  
The organization of  the UNG gene was determined by exten- 
sive Southern analysis with 12 different restriction endonu- 
cleases as described in section 2. Previous attempts to isolate 
genomic sequences from two phage libraries and a cosmid li- 
brary were unsuccessful, apparently due to an extreme under- 
representation of UNG genomic sequences in the library. At 
this level of resolution, the gene was found to be 13 kb long and 
to contain 4 exons (Fig. 1). The complete gene was contained 
on a 17 kb XbaI fragment. The approximate size of the last exon 
was verified by PCR amplification of a 725 bp region corre- 
sponding to position 1,230 to 1,955 in the eDNA. 
Digestion with RmaI and hybridization with the 5'-terminal 
cDNA probe identified a fragment of 1.3 kb containing the first 
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Fig. 1. Structure of the UNG gene. Model of the gene structure as 
determined by extensive Southern analysis of human genomic DNA 
using TaqI, lOnaI, NcoI, EcoRV, EcoRI, BglII, SacI, PvuII, HindIII, 
BglI, PstI and BamHI. All known sites for/bnaI, NeoI, EeoRV, PstI 
and BglII are shown. 
exon, and parts of the promoter and first intron. Using this 
information, we cloned the promoter egion by inverse PCR. 
The PCR product was sequenced and found to contain 387 bp 
of the sequence upstream of the eDNA start, 280 bp of the first 
exon, the first exordintron boundary and 480 bp of the first 
intron. The upstream sequence (Fig. 2) is very GC rich, lacks 
a TATA box, and was identified by the 'CpG plot' program [29] 
as a part of a CpG island (Fig. 3) [30]. The upstream sequence 
contains putative binding sites for several proteins regulating 
transcription (Table 1). Except for the putative API  site, all 
elements listed are identical to the reported consensus se- 
quences. The proposed AP1 consensus ite is 5'-CTGACT- 
CA-Y and the putative site in the UNG promoter is 
Table 1 
Putative recognition sites for transcription factors in the regulatory 
region of the UNG gene 
ELEMENT POSITION SEQUENCE REF. 
PEA3 18-  23 AGGAAG [47] 
AP1 67-  74 CTGACTCG [32] 
AP2 135 - 142 CCCATGGG [48] 
Y'YI 136 - 139 CCAT [43] 
Y'YI 146 - 149 CCAT [43] 
CCAAT 163 - 167 CCAAT [49] 
YY1 186 - 189 CCAT [43] 
CCAAT 194 - 198 CCAAT [50] 
Yi 213 - 223 cccrCCTGGCT [44] 
CCAAT 235 - 239 CCAAT [45] 
SPI 253 - 258 GGGCGG [51 ] 
E2F 279 - 288 GCCGCGAAAA [46] 
c-MYC 292 - 297 CACGTG [52] 
SP I 308 - 313 GGGCGG [51] 
SP1 318 - 323 GGCGGG [51] 
YYI 377 - 380 CCAT [43] 
CCAAT 428 - 432 CCAAT [45] 
182 T. Haug et al./FEBS Letters 353 (1994) 180-184 
1 ACTAGGGGGT GAAGGGGGAG AAGGCGGTG GGCCCCGCCT GACGGAGGGC GTGCAGGATC OCGCCTCTGA 
71 CTCGGTAAAC CCGGGCTCCG CTTTCCAAAT AGCCTCCACG TGTTCAAAAT AGCCGCCGCT GTCCCCCATG 
141 GGCCGCCATG CTAAAGGGCC ACCCAATGGG AACGCGTCTC GGGGCCCATG GCGCCAATCC GCGCGCCACA 
211 GGCCCTCCTG GCTCGGTGCG CTGTCCAATC AGAGGGGAGA GGGGGCGGGA CCCAGAGGGA GGTTTTTTGC 
281 CGCGAAAAGA CCACGTGGGG ACGCGGTGGG GCGGGTCTGG CGGGGGTGGG CACCTCTGT CCAGGGTTCC 
351 CGGTCACCGC GACGCTCCTC GGGAAGCCAT AGGGCGCCTC CCAGCCCGTC TCCCCGCTCC AGTTTAGAAC 
ACCTGTTCCA 
70 
140 
210 
280 
350 
420 
490 
560 
630 
700 
primer 2+ 
491 ___e,k~r~_G__Tc~__~_e_T_a_e_e_~__T_~occa~ = rTa~cc  a~=rraco  ~cacc~aoo ~a~aaccGc  
- -  - -  - -  - J p r i m e r  1+ 
561 TGCAGCTCTT GAGC~G_C_CT_C T_~ _~_C_C___ACT_T_~GGC CATCCCAGeC A~G~CC CG~CTGGGCA 
pr imer 1- 
631 ~ c ~  a~cacc~ ccTc~c~9_~e_ ,~e_~GT_ ,~_~ce~TecA ~ W ~ Q  
primer 2- 
701 GCCGCGGCCC TGCTCAGACT CGCGGCCCGC AACGTGCCCG TGGGCTTTGG AGAGAGCTGG AAGAAGCACC 770 
771 TCAGCGGGGA GTTCGGGAAA CCGTATTTTA TCAAGg~aaa tatggaaatg caccttccat aagggtaaa~ 840 
841 gtggaggctg ccggcccttt tgacttgtta gtgtagccgg ccaagt~cat gtttccgtag gcttaggttg 910 
911 tacccccttc cacctccttt actcacaaag ggggtaaaag aaagtcatl~a tgtttcactc tgcggcttta 980 
981 tattggttaa agttgttaac gacccgcgag atgatatcat ggattcattt aagtcacata gtctattgtc 1050 
1051 caggaaaggc tggcgtagta aaatcaccaa ctatcctgaa tgaaacctgg cttgagcttt aaaaagccgt 1120 
1121 gaggagtggc ac&gtcagga cccagcccag agaaagaggc aaggaattga ccttattgaa ccacttaggt 1190 
1191 gggggggcag gcactgtttt tgtt~gtagt ttr-ttaaaag aatttggaca taacatgaca aagaactaat 1260 
1261 gatgttccaa ataacttgca cta 
Fig. 2. The nucleotide sequences of the UNG promoter, first exon and a part of the first intron. The first exon is shown in bold letters and the first 
intron in small etters. The start of translation is indicated by double underlining at position 495. Primers used for inverse PCR are also shown. The 
nucleotide sequence will appear in the EMBL, GenBank and DDBJ Nucleotide Sequence databases under Accession Number X79093. 
5'-CTGACTCG-Y. However, yeast and Chinese hamster ana- 
logs of human Apl  are known to bind to this sequence [31,32]. 
Interestingly, the promoter contains an E2F-binding sequence 
upstream of two SP 1 elements close to the transcription i itia- 
tion region. 
A number of clones obtained as nested deletions were se- 
quenced to accurately define their structure and the most infor- 
mative clones were used for transient ransfection of HeLa 
cells. The observed activities relative to the activity detected 
with pGL2-ProB are given in Fig. 4. The two SP1 sites located 
close to the site of transcription initiation and a putative 
c-MYC element were sufficient o support a transcription at 
some 27% using pGL2- ProB as reference (100%). Other impor- 
tant elements are localized between position 229 and 290. When 
this sequence, which contains putative sites for Spl, E2F and 
a CCAAT-box, is present in addition to the proximal SP1/c- 
MYC elements, 90% of the activity directed by the full-length 
construct is restored. Sequences between 136 and 229 (contain- 
ing two CCAAT boxes and an AP2 element) appear to exert 
negative control functions, since deletion of this region in- 
creases transcription. Finally, sequences between position 42 to 
136, which contain a putative site for binding of Ap 1, enhances 
transcription approximately 2-fold. 
Purified Spl was used in band shift assay with a promoter 
fragment containing the putative SP1 sites proximal to the 
transcription i itiation site. A strong, specific binding to the 
promoter fragment was observed (Fig. 5) indicating a role for 
Spl in regulation of transcription from the UNG gene. A spe- 
cific binding of Ap2 was detected using the same strategy with 
purified Ap2 and another fragment containing the AP2 site in 
the distal part of the upstream sequence. To identify binding 
of proteins of the E2F-family, nuclear extracts from HeLa cells 
and a 24-mer oligonucleotide containing the putative E2F site 
were used in a mobility shift assay. The shifts were quantita- 
tively demonstrated using a phosphor-imager (Fig. 6). This 
analysis revealed three bands of which at least wo (peak 2 and 
3) contain proteins binding to the E2F element as they are 
diminished upon addition of unlabelled E2F oligo and unaf- 
fected by addition of an unspecific ompetitor (panel A). When 
an E2F-1 antibody was included in the band shift mixture 
(panel B), peak 3 was shifted to peak 4. Thus, it appears that 
at least two different protein complexes may bind specifically 
to the E2F element. Furthermore, changing different combina- 
tions of each of two GC's in the putative E2F site with AT's 
(position 279/281, 281/282, 278/279, 280/282), the oligonucleo- 
tides lost their ability to compete out the specific binding to the 
labelled E2F oligo (data not shown). 
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Fig. 3. CpG plot of the promoter, first exon and a part of the first 
intron. Observed/expected CpG dinucleotides (unbroken line) and% 
G+C (broken line) are plotted against position in the se- 
quence of the promoter, first exon and a part of the first intron. One 
CpG island covers the whole upstream sequence and another one is 
present in the first exon. 
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Fig. 4. Promoter structure and relative activities of deletion clones. The model shows putative recognition sites in agreement with proposed consensus 
sequences and sites present in the different constructs used in transient transfection fHeLa cells. The detected luciferase activity from each construct 
relative to the activity directed by the full length construct (pGL2-ProB) is given together with the standard eviation calculated from four experiments. 
The numbering indicates the start position of each construct, pGL2-Basic, not containing the UNG promoter, is used as negative control. The 
luciferase activity in extracts from HeLa cells transfected with pGL2-ProB (100%) was about 15 ng luciferase/mg protein (7.5 x 10" cpm/mg protein) 
as calculated from experiments in which purified luciferase protein was used under similar buffer conditions. 
4. Discussion 
The UNG promoter lacks a TATA box and is located within 
a CpG island. This finding, together with the ubiquitous expres- 
sion of UNG classifies the UNG gene as a house keeping ene 
[29]. Promoters containing CpG islands are thought to have an 
open chromatin structure facilitating the binding of transcrip- 
tion factors to the promoter [33]. 
The promoter proximal SP1 elements were clearly necessary 
for transcription, in agreement with the role of Spl as an ubiq- 
uitous transcription factor that seems to be essential in many 
TATA-less promoters [34-36]. The E2F element in position 279 
to 288 may explain the previously observed cell cycle regulation 
of the UNG gene, which is induced late in the Gl-phase [12]. 
E2F sites have been found in several genes essential for the 
Spl Ap2 
1 2 3 4 1 234  
Fig. 5. Spl and Ap2 binding analysis. In both autoradiograms lane 1 
contains the labelled promoter f agment; lane 2 contains the fragment 
incubated with the purified factor; lane 3 contains the labelled fragment 
incubated with purified factor and a 10-fold excess of a specific ompet- 
itor (Spl or Ap2 binding oligonucleotide (Promega)), lane 4 contains 
the labelled fragment incubated with purified factor and 10-fold excess 
of an unspecific competitor (GRE binding oligo (Promega)). 
S-phase, and which exhibit a similar pattern of cell cycle regula- 
tion (reviewed in [37]). 
In addition to E2F, elements like AP1 and PEA3 are com- 
mon to some of the genes that accumulate heir protein prod- 
ucts in the S-phase. The DNA polymerase ~ promoter contains 
binding sites for Apl, Ap2, Spl, E2F, Pea3 as well as CCAAT- 
boxes [38, 39], all of which are present in the UNG promoter. 
Transient transfections revealed that the region from 42 to 136, 
which contains aputative AP1 element, enhances transcription 
from the UNG promoter some 2-fold. Pea3 seems to recognize 
enhancer elements and often cooperates with Apl [40,41]. 
PEA3 is shown to be activated by different factors, including 
the oncogene products of c-Ha-ras and v-src [42], indicating a 
role for Pea3 in the control of proliferation. 
Furthermore, the upstream sequence in the UNG gene con- 
tains a AP2 site (position 135 to 142) which was verified in band 
shift assays with purified Ap2, and three CCAAT-boxes sepa- 
rated by approximately 30base pairs. When parts of this region 
are deleted from the constructs (constructs called A-192, A-204 
and A-229), the transcription activity increases, indicating the 
presence of a negatively regulating region in the promoter. 
Furthermore, the regulatory factor YY 1, shown to activate and 
repress promoter activity by bending DNA, is binding to the 
weak consensus CCAT [43] present at three places from posi- 
tion 136 to 189. We have also noticed that a putative site for 
the Yi protein is present. A GI/S specific binding to the Yi site in 
the murine thymidine kinase promoter has been reported [44]. 
In conclusion, the regulation of UNG transcription seems to 
involve several activating and repressing regulators. Noticably, 
an E2F element known to be involved in cell cycle regulation 
of other genes induced late in the Gl-phase is also present in 
the UNG gene, which otherwise resembles typical cell cycle 
regulated genes and house keeping genes that often lack a 
TATA box and frequently contain one or more CpG islands 
in the 5'-part of the gene. 
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Fig. 6. E2F binding analysis. The figures show phosphor-imager scans 
of E2F mobility shift gels. Scans are performed along the lanes, so that 
direction of migration is from left to right in the figure. The graphs 
show the intensity of the radioactivity along the lanes, and the shifted 
bands are represented as peaks. Panel A: control of specificity. The E2F 
oligo was incubated with HeLa nuclear extract and no competitor 
( ), nuclear extract and unlabelled E2F oligo as specific ompetitor 
(-.-.-) or nuclear extract and an Octl oligo as unspecific ompetitor 
(.....). Radioactivity of the unshifted oligo is not shown. Panel B: gel 
mobility shift with the putative E2F oligo and HeLa nuclear extract 
with (.....) and without E2F-1 specific antibody ( ). 
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